Trials / Completed
CompletedNCT03102489
Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Study of BP101 in Healthy Volunteers
Double-blind, Randomized, Placebo-controlled Study of the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of BP101 After Multiple Doses Administration in Healthy Volunteers
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 18 (actual)
- Sponsor
- Ivix LLX · Industry
- Sex
- Female
- Age
- 18 Years – 40 Years
- Healthy volunteers
- Accepted
Summary
Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Study of BP101 in Healthy Volunteers.
Detailed description
Double-blind, randomized, placebo-controlled study of the safety, tolerability, pharmacokinetics and pharmacodynamics of BP101 after multiple doses administration in healthy volunteers.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | BP101 | Nasal spray |
| DRUG | Placebo | Nasal spray |
Timeline
- Start date
- 2017-02-22
- Primary completion
- 2017-06-21
- Completion
- 2017-09-19
- First posted
- 2017-04-05
- Last updated
- 2020-02-11
Locations
1 site across 1 country: Russia
Source: ClinicalTrials.gov record NCT03102489. Inclusion in this directory is not an endorsement.